Is this your firm? Get featured or correct your listing →
Strategy
Stages
SeedSeries A
Sectors
Technology
Geographies
USABethesda, Maryland, USA
Check size
$100K - $5MRecent changes
- Oct 15, 2026Oct 15, 2026Invested in OMass Therapeutics (Series C, $310M) ValueSpectrum
Portfolio
1 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | OMass Therapeutics | Series C | Participated | $310M | — | Bain Capital Life SciencesLeadunverifiedForbionLeadunverifiedGoogle Ventures (GV)unverifiedNorthpond VenturesunverifiedSanofi VenturesunverifiedBritish Business BankunverifiedJanus Henderson InvestorsunverifiedNovo HoldingsSynconaOxford Science EnterprisesSV Health Investors+2 more | ValueSpectrum |
Co-Investors
6Similar Firms
overlapping sector, stage or regionLatest Pulse
Northpond Ventures FAQ
What companies has Northpond Ventures invested in?
Northpond Ventures' portfolio includes OMass Therapeutics.
Who does Northpond Ventures co-invest with most?
In the rounds Value Add tracks, Northpond Ventures most often invests alongside Bain Capital Life Sciences (1 shared deal), British Business Bank (1 shared deal), Forbion (1 shared deal), Google Ventures (GV) (1 shared deal), Janus Henderson Investors (1 shared deal).
Sources & methodologyshow
Where these figures come from
- ValueSpectrumValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.